Europe (15 Countries) Markets For Soft Tissue Reinforcement And Regeneration - 2011-2021
NEW YORK, June 30, 2015 /PRNewswire/ -- The European market for soft tissue reinforcement and regeneration differs substantially from the U.S. market; the European adoption rate of biologics is significantly lower than that of the United States. Since biologic matrices are often significantly more expensive than their synthetic counterparts in Europe, the low biologic adoption rate has a substantial negative impact on the soft tissue market as a whole. Due to the strictly evidence-based approach throughout Europe, the benefits of biologic products, such as expedited healing and reduced likelihoods of graft rejection, are not seen to outweigh their high costs.
The European market for soft tissue reinforcement and regeneration includes graft devices that are designed to reinforce and regenerate soft tissues. Soft tissues are defined as aggregations of similarly specialized cells which collectively function to connect, support or surround other structures and organs of the body. These tissues include tendons, ligaments, fascia, skin, fibrous tissues, fat, synovial membranes, muscles, nerves and blood vessels. Collagen, the most abundant protein in mammals, is one of the characteristic elements inside the extracellular matrix of soft tissue and, as such, plays a critical role in soft tissue repair.
Because soft tissue essentially makes up the majority of a person, and there are countless medical conditions associated with soft tissue problems, a select group of large markets related to soft tissue repair will be covered in this report, including breast reconstruction, hernia repair, dural repair, vaginal slings, skin repair, sports medicine and tendon reinforcement, and dental soft tissue regeneration. These indications were selected because they feature the use of synthetic mesh and biological matrices to reinforce and regenerate deficient areas.
There are three primary classes of soft tissue reinforcement and regeneration devices: allografts, xenografts, and alloplasts.
Read the full report: http://www.reportlinker.com/p03039742-summary/view-report.html
About Reportlinker
ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - instantly, in one place.
http://www.reportlinker.com
__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001
SOURCE Reportlinker
Share this article